Mate - they have gone from no chance to stable, i.e. no worsening of their tumours. This within the constraints of the dosage regimen. Great result, even if I may have emotional ties to this result.
The biggest concern to me is moving the trials to Australia. I may have read it wrong, but I hope there is continuing treatment of those patients in the US so that further data is generated on disease control or otherwise.
Having said that I dipped my toe in the water today, having watched for a year, as I believe there is significant medical benefit with these drugs.
The other concern is manufacturing for PTX-100. I'm sure they can overcome that, but having been in the industry at that stage, I know that it will take time. If there are further good results on PTX-100 & PTX-200 maybe the time for big Pharma to jump in.
- Forums
- ASX - By Stock
- Ann: Encouraging data from PTX-200 ovarian cancer trial
Mate - they have gone from no chance to stable, i.e. no...
-
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.43M |
Open | High | Low | Value | Volume |
4.3¢ | 4.5¢ | 4.3¢ | $8.665K | 198.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 162069 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 1817 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 162069 | 0.043 |
4 | 282657 | 0.042 |
6 | 439000 | 0.041 |
8 | 1217984 | 0.040 |
2 | 210000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 1817 | 1 |
0.048 | 2664 | 1 |
0.049 | 70000 | 1 |
0.051 | 277227 | 2 |
0.053 | 12000 | 1 |
Last trade - 14.54pm 21/10/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online